Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia

Annals of Hematology

Volumn 82, Issue 5, 2003, Pages 290-294

  Zoghlami Rintelen, Claudia ^a   Weltermann, A ^a   Bittermann, C ^b   Kyrle, P A ^a   Pabinger, I ^a   Lechner, K ^a   Wenzl, E ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic immune thrombocytopenia; Efficacy; Safety; Splenectomy

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; DANAZOL; HAEMOPHILUS VACCINE; IMMUNOGLOBULIN; PNEUMOCOCCUS VACCINE; PREDNISOLONE; STEROID; VINBLASTINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUSTRIA; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; SAFETY; SEPTICEMIA; SPLENECTOMY; STEROID THERAPY; SURVIVAL; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0038514855     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0550-8     Document Type: Article

References (31)

1. Bell WR Jr (2000) Long-term outcome of splenectomy for idiopathic thrombocytopenic purpura. Semin Hematol 37 [Suppl 1]:22-25
2. Bellucci S, Charpak Y, Chastang C, Tobelem G (1988) Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults. Blood 71:1165-1169
3. Berchtold P, McMillan R (1989) Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 74:2309-2317
4. Bussel JB (2000) Overview of idiopathic thrombocytopenic purpura: new approach to refractory patients. Semin Oncol 27:91-98
5. Chen CC, Ho CH, Wu TS, Wu JS, You JY, Chau WK, Hsu HC, Gau JP (2001) Predictive prognostic factors after splenectomy in patients with idiopathic thrombocytopenic purpura. Haematologica 86:663-664
6. Choi CW, Kim BS, Seo JH, et al. (2001) Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. Am J Hematol 66:197-202
7. Cooper N, Woloski MR, Fodero EM, Novoa M, Leber M, Beer JH, Bussel JB (2002) Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenia purpura to avoid splenectomy? Blood 99:1922-1927
8. DiFino SM, Lachant NA, Kirshner JJ, Gottlieb AJ (1980) Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 69:430-442
9. El-Alfy MS, Kamel MM, Shahein N (2001) 5-15 year follow up postsplenectomy in chronic immune thrombocytopenic purpura (ITP) in children. Blood 98 [Suppl]:2184a
10. Emilia G, Morselli M, Luppi M, Longo G, Marasca R, Gandini G, Ferrara L, D'Apollo N, Potenza L, Bertesi M, Torelli G (2002) Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. Blood 99:1482-1485
11. Fabris F, Tassan T, Ramon R, et al. (2001) Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol 112:637-640
12. Fass SM, Hui TT, Lefor A, Maestroni U, Phillips EH (2000) Safety of laparoscopic splenectomy in elderly patients with idiopathic thrombocytopenic purpura. Am Surg 66:844-847
13. Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94:909-913
14. George JN, Woolf SH, Raskob GE, et al. (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3-40
15. Gibson M, Sehon JK, White S, Zibari GB, Johnson LW (2000) Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review. Am Surg 66:952-954
16. Karpatkin S (1985) Autoimmune thrombocytopenic purpura. Semin Hematol 22:260-288
17. Katkhouda N, Hurwitz MB, Rivera RT, et al. (1998) Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg 228:568-578
18. Kojouri K, Vesely SK, George JN (2001) Splenectomy for idiopathic thrombocytopenic purpura (ITP): a systemic literature review of individual patient data to access predictors of response, long-term outcomes, and complications. Blood 98 [Suppl]:3856a
19. Louwes H, Vellenga E, Houwerzijl EJ, de Wolf JT (2001) Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission. Ann Hematol 80:728-732
20. Mazzucconi MG, Arista MC, Peraino M, et al. (1999) Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. Eur J Haematol 62:219-222
21. Mazzucconi MG, Francesconi M, Fidani P, et al. (1985) Treatment of idiopathic thrombocytopenic purpura (ITP): results of a multicentric protocol. Haematologica 70:329-336
22. McMillan R (1997) Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 126:307-314
23. Pizzuto J, Ambriz R (1984) Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American Group on Hemostasis and Thrombosis. Blood 64:1179-1183
24. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549-2554
25. Radaelli F, Faccini P, Goldaniga M, et al. (2000) Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpura. Haematologica 85:1040-1044
26. Rovó A, Penchansky D, Santos I, Ceresetto J, Celebrín L, Maneyro A, Sanchez Avalos J, Lanari E, Ferro H, Korin J (2001) Is it possible to predict which patient will respond to splenectomy in ITP and for how long? An update. Blood 98 [Suppl]:3872a
27. Saleh MN, Gutheil J, Moore M, et al. (2000) A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Semin Oncol 27:99-103
28. Stasi R, Pagano A, Stipa E, Amadori S (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98:952-957
29. Stasi R, Stipa E, Masi M, et al. (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98:436-442
30. Winde G, Schmid KW, Lugering N, et al (2002) Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura. J Am Coll Surg 183:565-574
31. Zaja F, Iacona I, Masolini P, et al. (2002) B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica 87:189-195